Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND

Nephrology Dialysis Transplantation

Volumn 30, Issue 8, 2015, Pages 1322-1329

  Murea, Mariana ^a   Hsu, Fang Chi ^a   Cox, Amanda J ^a   Hugenschmidt, Christina E ^a   Xu, Jianzhao ^a   Adams, Jeremy N ^a   Raffield, Laura M ^a   Whitlow, Christopher T ^a   Maldjian, Joseph A ^a   Bowden, Donald W ^a   Freedman, Barry I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

albuminuria; brain; cognitive function; kidney disease; magnetic resonance imaging

Indexed keywords

CREATININE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

AGED; ALBUMINURIA; ARTICLE; BODY MASS; BRAIN DISEASE; BRAIN FUNCTION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COGNITION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIGIT SYMBOL SUBSTITUTION TEST; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; EDUCATION; EUROPEAN AMERICAN; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL ASSESSMENT; GLOMERULUS FILTRATION RATE; GRAY MATTER; HIPPOCAMPUS; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LEARNING TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REY AUDITORY VISUAL LEARNING TEST; SEMANTICS; STROOP TEST; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE; WHITE MATTER; BRAIN; CAUCASIAN; CHRONIC KIDNEY FAILURE; COGNITION DISORDERS; COMPLICATION; DIABETES COMPLICATIONS; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY; UNITED STATES;

ALBUMINURIA; BRAIN; COGNITION DISORDERS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES;

EID: 84939606051     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv030     Document Type: Article

References (46)

1. Moodalbail DG, Reiser KA, Detre JA et al. Systematic review of structural and functional neuroimaging findings in children and adults with CKD. Clin J Am Soc Nephrol 2013; 8: 1429-1448
2. Kurella M, Chertow GM, Fried LF et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 2005; 16: 2127-2133
3. Khatri M, Wright CB, Nickolas TL et al. Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke 2007; 38: 3121-3126
4. Kurella TM,Wadley V, Yaffe K et al. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis 2008; 52: 227-234
5. Weiner DE, Bartolomei K, Scott T et al. Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis 2009; 53: 438-447
6. Barzilay JI, Gao P, O'DonnellMet al. Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies. Arch Intern Med 2011; 171: 142-150
7. Kurella TM, Muntner P,Wadley Vet al. Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis 2011; 58: 756-763
8. Helmer C, Stengel B, Metzger M et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology 2011; 77: 2043-2051
9. Takahashi W, Tsukamoto Y, Takizawa S et al. Relationship between chronic kidney disease and white matter hyperintensities on magnetic resonance imaging. J Stroke Cerebrovasc Dis 2012; 21: 18-23
10. Naganuma T, Takemoto Y, Shoji T et al. Factors associated with cerebral white matter hyperintensities in haemodialysis patients. Nephrology (Carlton) 2012; 17: 561-568
11. Umemura T, Kawamura T, Umegaki H et al. Association of chronic kidney disease and cerebral small vessel disease with cognitive impairment in elderly patients with type 2 diabetes. Dement Geriatr CognDis Extra 2013; 3: 212-222
12. Nyquist PA, Bilgel MS, Gottesman R et al. Extreme deep white matter hyperintensity volumes are associated with African American race. Cerebrovasc Dis 2014; 37: 244-250
13. Schneider BC, Gross AL, Bangen KJ et al. Association of vascular risk factors with cognition in a multiethnic sample. J Gerontol B Psychol Sci Soc Sci 2014; 10: 1-13
14. Sink KM, Divers J, Whitlow CTet al. Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND. Diabetes Care 2015; 38: 206-212
15. Palmer N, Sink K, Smith Cet al. Kidney disease and cognitive function:African American-Diabetes Heart Study MIND. Am J Nephrol 2014; 40: 200-207
16. Bowden DW, Cox AJ, Freedman BI et al. Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications. Rev Diabet Stud 2010; 7: 188-201
17. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
18. Tzourio-Mazoyer N, Landeau B, Papathanassiou D et al. Automated anatomical labeling of activations in SPM using amacroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15: 273-289
19. Maldjian JA, Laurienti PJ, Kraft RA et al. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003; 19: 1233-1239
20. Schmidt P, Gaser C, Arsic M et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis. Neuroimage 2012; 59: 3774-3783
21. Maldjian JA, Whitlow CT, Saha BN et al. Automated white matter total lesion volume segmentation in diabetes. AJNR Am J Neuroradiol 2013; 34: 2265-2270
22. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987; 48: 314-318
23. Lezak M, Howleson D, Loring D. Neuropsychological Assessment. 2004. New York: Oxford University Press
24. Houx PJ, Jolles J, Vreeling FW. Stroop interference: aging effects assessed with the Stroop Color-Word Test. Exp Aging Res 1993; 19: 209-224
25. Strauss E, Sherman EMS. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. Oxford University Press, 2006
26. Wechsler D. Manual for the Wechiser Adult Intelligence Scale-Revised. New York: Psychological Corporation, 2014
27. Jongen C, van der GJ, Kappelle LJ et al. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia 2007; 50: 1509-1516
28. Jassal SK, Kritz-Silverstein D, Barrett-Connor E. A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo study. Am J Epidemiol 2010; 171: 277-286
29. Murray AM, Barzilay JI, Lovato JF et al. Biomarkers of renal function and cognitive impairment in patients with diabetes. Diabetes Care 2011; 34: 1827-1832
30. Knopman DS, Mosley TH, Jr, Bailey KR et al. Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships. J Neurol Sci 2008; 271: 53-60
31. van Elderen SG, de RA, de Craen AJ et al. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology 2010; 75: 997-1002
32. Verdelho A, Madureira S, Moleiro C et al. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 2010; 75: 160-167
33. Anan F, Masaki T, Iwao T et al. The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients. Curr Med Res Opin 2008; 24: 1561-1567
34. Brickman AM, Schupf N, Manly JJ et al. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol 2008; 65: 1053-1061
35. White H, Boden-Albala B,Wang C et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 2005; 111: 1327-1331
36. DeCarli C, Reed BR, JagustWet al. Brain behavior relationships among African Americans, whites, and Hispanics. Alzheimer Dis Assoc Disord 2008; 22: 382-391
37. Manly JJ, Tang MX, Schupf N et al. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol 2008; 63: 494-506
38. Bugnicourt JM, Godefroy O, Chillon JM et al. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol 2013; 24: 353-363
39. Gorelick PB, Scuteri A, Black SE et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 2672-2713
40. Rincon F, Wright CB. Vascular cognitive impairment. Curr Opin Neurol 2013; 26: 29-36
41. Solomon SD, Lin J, Solomon CG et al. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation 2007; 116: 2687-2693
42. Hermans MM, Henry RM, Dekker JM et al. Albuminuria, but not estimated glomerular filtration rate, is associated with maladaptive arterial remodeling: the Hoorn Study. J Hypertens 2008; 26: 791-797
43. Friden V, Oveland E, TenstadOet al. The glomerular endothelial cell coat is essential for glomerular filtration. Kidney Int 2011; 79: 1322-1330
44. Becker BF, Chappell D, Jacob M. Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol 2010; 105: 687-701
45. BirdsillAC, Koscik RL, JonaitisEMet al. Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function. Neurobiol Aging 2014; 35: 769-776
46. Dyer AR, Greenland P, Elliott P et al. Evaluation of measures of urinary albumin excretion in epidemiologic studies. Am J Epidemiol 2004; 160: 1122-1131